Search - tctmd.com

Displaying 21 - 34 of 34

Sort: Relevancy | Date

News Conference News TCT 2018

More Evidence That the MitraClip Might Be Useful in the Tricuspid Valve

Todd Neale

September 24, 2018

News Industry News

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

August 30, 2017

News Daily News

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Yael L. Maxwell

April 04, 2017

News Industry News

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

July 13, 2016

News Industry News

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

December 02, 2015

News Industry News

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

October 12, 2015

News Industry News

Mitralign Receives FDA Approval for Percutaneous Tricuspid Repair Early Feasibility Study

August 31, 2015

News Daily News

人类首例经导管三尖瓣修复证明可行

April 03, 2015

News Daily News

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

April 03, 2015

News Daily News

Reparación Transcatéter de la Válvula Tricúspide Viable en el 1er Caso en Humanos

April 03, 2015

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

News Daily News

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Caitlin E. Cox

July 11, 2013

News Daily News

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

Caitlin E. Cox

April 26, 2013

News Daily News

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Caitlin E. Cox

April 26, 2013

Advertisement

More Evidence That the MitraClip Might Be Useful in the Tricuspid Valve

NaviGate Cardiac Structures Inc. (“NCSI”) reports world’s first successful transcatheter implantation of 52-mm tricuspid valve into a transplanted-heart patient to correct “torrential” tricuspid regurgitation (TR)

SCOUTing the ‘Forgotten Valve’: Promise for a New Percutaneous Treatment Option in Tricuspid Regurgitation

Mitralign Completes Enrollment in First Phase of US Early Feasibility Study on Tricuspid Repair

Mitralign Announces Enrollment of First U.S. Subject in Percutaneous Tricuspid Repair Study

Mitralign to Provide Update on Transcatheter Tricuspid Repair at TCT 2015

Mitralign Receives FDA Approval for Percutaneous Tricuspid Repair Early Feasibility Study

人类首例经导管三尖瓣修复证明可行

Transcatheter Tricuspid Valve Repair Appears Feasible in First-in-Human Case

Reparación Transcatéter de la Válvula Tricúspide Viable en el 1er Caso en Humanos

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

PARTNER Substudy Looks at Echocardiographic Differences Between TAVR, Surgery

El Subestudio PARTNER Analiza las Direrencias Ecocardiográficas existentes entre la TAVR y la Cirugía

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content